Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 6 vs 12 weeks of antibiotic therapy for osteitis in diabetic neuropathic foot
2006-006245-14Phase 4Active
- Sponsor
- Centre Hospitalier de Tourcoing
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rifampicin, ofloxacin, levofloxacin, fusidic acid, clindamycin and 5 more in osteomyelitis (OM), type 2 diabetes mellitus (T2DM), diabetic foot ulcer (DFU) and 1 more (2 arms), sponsored by Centre Hospitalier de Tourcoing. Primary endpoint: Therapeutic success rate at end of antibiotic treatment. Started Jan 2007; status: active.
02
Drugs
rifampicinofloxacinlevofloxacinfusidic acidclindamycin
03
Conditions
osteomyelitis (OM)type 2 diabetes mellitus (T2DM)diabetic foot ulcer (DFU)foot osteomyelitis
Beyond the preview
Go deeper on 2006-006245-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006245-14.